Nicholas G Cuccolo1,2, Christine O Kang1,2, Elizabeth R Boskey3,4, Ahmed M S Ibrahim2, Louise L Blankensteijn2, Amir Taghinia1,5, Bernard T Lee2, Samuel J Lin2, Oren Ganor1,5. 1. Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02215, USA. 2. Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite 5A, Boston, MA, 02215, USA. 3. Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02215, USA. Elizabeth.Boskey@childrens.harvard.edu. 4. Center for Gender Surgery, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02215, USA. Elizabeth.Boskey@childrens.harvard.edu. 5. Center for Gender Surgery, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02215, USA.
Abstract
BACKGROUND: Chest reconstruction ('top surgery') is an important component of transition in the transmasculine population that can substantially improve gender incongruence. The aim of this study was to evaluate the demographic characteristics, surgical technique, and postoperative outcomes following transmasculine chest surgery. METHODS: Using ICD codes, we identified all cases of gender-affirming transmasculine chest surgery from the ACS NSQIP database (2010-2017). CPT codes were used to categorize patients by reconstructive modality: reduction versus mastectomy (± free nipple grafting [FNG]). Univariate analysis was conducted to assess for differences in demographics, comorbidities, and postoperative complications. Multivariable regression analysis was used to control for confounders. RESULTS: A total of 755 cases were identified, of whom 591 (78.3%) were mastectomies and 164 (21.7%) were reductions. No significant differences were noted in terms of age or BMI. Mastectomies had shorter operative times, but similar length of stay compared to reductions. Rates of postoperative complications were low, with 4.7% (n = 28) of mastectomies and 3.7% (n = 6) of reductions experiencing at least one all-cause complications. Postoperative complication rates were not statistically different between mastectomy with (3.4%) and without (5.6%) FNG. After controlling for confounders, there was no difference in terms of risk of all-cause complications between reduction and mastectomy, with or without FNG. CONCLUSION: Mastectomy and reduction mammaplasty are both safe procedures for chest reconstruction in the transmasculine population. These results may be used to encourage shared decision making between patient and surgeon such that the reconstructive modality of choice best aligns with the desired aesthetic outcome. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
BACKGROUND: Chest reconstruction ('top surgery') is an important component of transition in the transmasculine population that can substantially improve gender incongruence. The aim of this study was to evaluate the demographic characteristics, surgical technique, and postoperative outcomes following transmasculine chest surgery. METHODS: Using ICD codes, we identified all cases of gender-affirming transmasculine chest surgery from the ACS NSQIP database (2010-2017). CPT codes were used to categorize patients by reconstructive modality: reduction versus mastectomy (± free nipple grafting [FNG]). Univariate analysis was conducted to assess for differences in demographics, comorbidities, and postoperative complications. Multivariable regression analysis was used to control for confounders. RESULTS: A total of 755 cases were identified, of whom 591 (78.3%) were mastectomies and 164 (21.7%) were reductions. No significant differences were noted in terms of age or BMI. Mastectomies had shorter operative times, but similar length of stay compared to reductions. Rates of postoperative complications were low, with 4.7% (n = 28) of mastectomies and 3.7% (n = 6) of reductions experiencing at least one all-cause complications. Postoperative complication rates were not statistically different between mastectomy with (3.4%) and without (5.6%) FNG. After controlling for confounders, there was no difference in terms of risk of all-cause complications between reduction and mastectomy, with or without FNG. CONCLUSION: Mastectomy and reduction mammaplasty are both safe procedures for chest reconstruction in the transmasculine population. These results may be used to encourage shared decision making between patient and surgeon such that the reconstructive modality of choice best aligns with the desired aesthetic outcome. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Entities:
Keywords:
Gender affirmation surgery; Mastectomy; Reduction mammaplasty; Top surgery; Transmasculine
Authors: Mona Ascha; Daniel C Sasson; Rachita Sood; Jeremy W Cornelius; Jacob M Schauer; Adariane Runge; Abigail L Muldoon; Noopur Gangopadhyay; Lisa Simons; Diane Chen; Julia F Corcoran; Sumanas W Jordan Journal: JAMA Pediatr Date: 2022-09-26 Impact factor: 26.796
Authors: Rachita Sood; Diane Chen; Abigail L Muldoon; Liqi Chen; Mary J Kwasny; Lisa K Simons; Noopur Gangopadhyay; Julia F Corcoran; Sumanas W Jordan Journal: J Adolesc Health Date: 2021-04-10 Impact factor: 5.012
Authors: Kara A Rothenberg; Rebecca C Gologorsky; J Carlo Hojilla; Annie Tang; Caitlin M Cohan; Genna Beattie; Karen M Yokoo Journal: Ann Plast Surg Date: 2021-07-01 Impact factor: 1.763
Authors: Valeria P Bustos; Samyd S Bustos; Andres Mascaro; Gabriel Del Corral; Antonio J Forte; Pedro Ciudad; Esther A Kim; Howard N Langstein; Oscar J Manrique Journal: Plast Reconstr Surg Glob Open Date: 2021-03-19